BVF Partners, 10% Stockholder, Affiliate of Director: MoonLake Immunotherapeutics MLTX Planned sale · Filed 03/31

Trade details

Type: Planned sale notice
Stock: MoonLake Immunotherapeutics MLTX
Person: BVF Partners10% Stockholder, Affiliate of Director
Planned sale date: 26/03/31
Filed: 26/03/31

5.2% of shares outstanding to be sold

MoonLake Immunotherapeutics trades, last 26 weeks

What else happened in MoonLake Immunotherapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

BVF Partners's recent trades

BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$89.2M
837,914 sh
$89.2M
Filed 06/26
Traded 06/26
BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$66.8M
627,597 sh
$66.8M
Filed 06/26
Traded 06/26
BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$12.1M
113,289 sh
$12.1M
Filed 06/26
Traded 06/26
BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$5.5M
51,858 sh
$5.5M
Filed 06/26
Traded 06/26
BVF PartnersSEE REMARKS and Footnotes
Planned saleKymera Therapeutics
Planned sale
Kymera Therapeutics
KYMR
$189.9M
1,630,658 sh
$189.9M
Filed 06/26
Traded 06/26